Dr. Esther Jacobs is an Associate Principal Scientist at AstraZeneca, where she specializes in advancing pharmaceutical innovation through her expertise in amorphous solid dispersions (ASDs), lipid-based formulations (LBFs), and hot melt extrusion (HME). She holds a PhD in Pharmaceutical Sciences from Queen’s University Belfast, where her research focused on drug delivery of amorphous polymeric nanoparticles using hot-melt extrusion.

At AstraZeneca, Esther’s role focuses on the development and optimization of oral formulations of poorly soluble and complex synthetic molecules from early preclinical until early clinical development.